BiomX, Inc. Annual report pursuant to Section 13 and 15(d)

Significant Accounting Policies (Details) - Schedule of financial assets and liabilities - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash equivalents:
Money market funds	$ 30,007	$ 30,000
Foreign exchange contracts receivable	62	90
Total assets	30,069	30,090
Liabilities:
Contingent consideration	175	83
Total liabilities	175	83
Level 1 [Member]
Cash equivalents:
Money market funds	30,007	30,000
Total assets	30,007	30,000
Liabilities:
Contingent consideration
Total liabilities
Level 2 [Member]
Cash equivalents:
Money market funds
Foreign exchange contracts receivable	62	90
Total assets	62	90
Liabilities:
Contingent consideration
Total liabilities
Level 3 [Member]
Cash equivalents:
Money market funds
Total assets
Liabilities:
Contingent consideration	175	83
Total liabilities	$ 175	$ 83